期刊文献+

保肝消脂颗粒对非酒精性脂肪肝大鼠肝组织瘦素的影响 被引量:5

Effect of Baoganxiaozhi Granule on Leptin of Liver Tissue In Rats with Nona Lcoholic Liver Disease
暂未订购
导出
摘要 目的:通过观察非酒精性脂肪肝大鼠肝组织瘦素的变化,探讨中药降脂颗粒治疗非酒精性脂肪肝可能的作用机制。方法:60只雄性SD大鼠随机分为空白对照组、模型组、辛伐他汀组和保肝消脂高、中、低剂量组。治疗8周后处死,记录肝指数,进行肝组织病理学检测,酶联免疫方法测定肝组织匀浆中瘦素水平。结果:与空白对照组相比,造模组肝指数、肝组织中的瘦素水平显著升高(P<0.05),经保肝消脂颗粒治疗后,肝指数、肝匀浆组织中瘦素水平明显下降,其中保肝消脂颗粒中、高剂量组与模型组差异显著。结论:保肝消脂颗粒可有效地降低肝组织匀浆瘦素水平,该作用可能是其治疗非酒精性脂肪肝的作用机理之一。 Objective: To observe the effect of baoganxiaozhi Granule on leptin of liver tissue in rats with nona lcoholic liver disease,to explore the potencial mechanism of the herb on NAFLD.Methods: 60 Male SD rats were randomly divided into six groups: control group;model group;sinvastatin group;baoganxiaozhi Granule group of high dose,medium dose and low dose.The rats in the model group;sinvastatin group;baoganxiaozhi Granule group were fed a fat-rich diet to establish NAFLD model with 8 weeks.After 8 weeks treatment,all rats were sacrificed.Records of liver index and the detection of liver histopathology,The levels of liver leptin were measured by enzyme linked immunosorbent assay(ELISA).Results: Compared with the control group,liver index,liver tissue leptin levels in model group were significantly higher(P 0.05),after treatment by baoganxiaozhi Granule,liver index,liver tissue homogenate leptin levels were significantly decline,which nourish the liver and reducer particles,high-dose group and model group significant difference.Conclusion: Baoganxiaozhi Granule can effectively reduce the liver tissue homogenate leptin levels,the effect may be one mechanism of action of its treatment of non-alcoholic fatty liver.
出处 《中医药学报》 CAS 2010年第4期31-33,共3页 Acta Chinese Medicine and Pharmacology
关键词 保肝消脂颗粒 非酒精性脂肪肝 大鼠 瘦素 Baoganxiaozhi Granule Nona lcoholic liver disease Rat Leptin
  • 相关文献

参考文献5

  • 1Schwimmer JB,Behling C,Newbury R,Deutsch R,Nievergelt C,Schork NJ,Lavine JE.Histopathologyof pediatric nonalcoholic fatty liver disease[J].Hepatology,2005,42:641-649.
  • 2Marchesini G,Marzocchi R,Agostini F,Bugianesi E.Nonalcoholic fatty liver disease and the metabolicsyndrome[J].Curr Opin Lipidol,2005,16:421 -427.
  • 3Yalniz M,Bahcecioglu IH,Ataseven H,UstundagB,Ilhan F,Poyrazoglu OK,Erensoy A.Serumadipokine and ghrelin levels in nonalcoholicsteatohepatitis[J].Mediators Inflamm,2006:34295.
  • 4ShklyaevS,AslanidiG,TennantM,PrimaV,KohlbrennerE,KroutovV,Campbell -ThompsonM,Crawford J,Shek EW,Scarpace PJ,ZolotukhinS.Sustained peripheral expression of transgeneadiponectin offsets the development of dietinducedobesity in rats[J].Proc Natl Acad Sci USA,2003,100:14217-14222.
  • 5戚丽,路中.非酒精性脂肪肝胰岛素抵抗及血清瘦素和脂联素水平的研究[J].中国中西医结合消化杂志,2006,14(3):167-170. 被引量:5

二级参考文献15

  • 1MAGER D, ROBERTS E. Nonalcoholic fatty liver disease[J]. CMAJ, 2005,173: 735-735.
  • 2SCHWIMMER J B, BEHLING C, NEWBURY R,et al. Histopathology of pediatric nonalcoholic fatty liver disease[J]. Hepatology, 2005,42 : 641 - 649.
  • 3ADAMS L A, LYMP J F, St SAUVER J,et al. The natural history of nonalcoholic fatty liver disease, a populatlon-based cohort study[J]. Gastroenterology,2005,129 : 113- 121.
  • 4ANGULO P, ALBA L M, PETROVIC L M, et al.Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease[J]. J Hepatol, 2004,41 : 943-949.
  • 5VUPPALANCHI R, MARRI S, KOLWANKAR D,et al. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study[J]. J Clin Gastroenterol, 2005,39:237- 242.
  • 6MARCHESINI G, BRIZI M, BIANCHI G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome[J]. Diabetes, 2001,50:1844- 1850.
  • 7MARCHESINI G, MARZOCCHI R, AGOSTINI F,et al. Nonalcoholic fatty liver disease and the metabolic syndrome[J]. Curr Opin Lipidol, 2005, 16:421-427.
  • 8YU A S, KEEFFE E B. Nonalcoholic fatty liver disease [J]. Rev Gastroenterol Disord, 2002,2:11-19.
  • 9AHIMA R S, FLIER J S. Leptin[J]. Annu Rev Physiol, 2000,62: 413- 437.
  • 10CHITTURI S, FARRELL G, FROST L,et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? [J]. Hepatology, 2002,36: 403-409.

共引文献4

同被引文献39

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部